Atlas Trials

Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients

Clinical trial NCT00225394 · COMPLETED

Trial details

NCT number
NCT00225394
Sponsor
University of Massachusetts, Worcester
Status
COMPLETED
Study type
OBSERVATIONAL
CMV DiseaseViral ResistanceRejectionDeath
Start date
2003-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.